AGP Executive Report
Last update: 11 hours agoAlcohol Shift: Gallup says drinking is at a record low in the U.S.—only 54% report drinking now, and just 13% say they sometimes drink too much, with fewer people viewing moderate drinking as healthy. Cannabis Policy Fight: Texas hemp shops sued to block new state rules tightening hemp-derived THC, arguing regulators unlawfully rewrote hemp definitions and are crushing businesses; the case seeks an emergency stop. Medical Cannabis Research: A Phase 3 NIDA-backed trial (PleoPharma) is moving forward for PP-01 to treat cannabis withdrawal in adults with cannabis use disorder, with $6.5M in NIH/NIDA funding. Clinical Signals: A placebo-controlled study found oral dronabinol (synthetic THC) reduced PTSD nightmare frequency and intensity, while another trial in Parkinson’s found a CBD/THC oil didn’t significantly improve pain or nonmotor symptoms. Public Health & Safety: Ireland’s HSE/Garda actions highlight “high-risk” cannabinoids in vapes and edibles, and a Benin teaching hospital opened a drug testing center screening for cannabis and other substances. Cannabis & Sleep/Alcohol Swap: A study on THC drinks reports many people drank less alcohol and reported better sleep and mood during use.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Cannabis-Based Oil Fails to Improve Pain or Nonmotor Symptoms in Parkinson Disease Study]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27693930-935721615-b237f6d5ccd92206f92128a11b3721457ba9ddb7-1950x1021-200x105.png)
